Listed Alternatives
AXA IM Alts manages a wide range of diversifying investment strategies in the liquid space.
*Not open for US investors
Our approach
All our listed alternative strategies are actively managed, based on a portfolio construction led by fundamental analysis and security selection. However, each of them relies on a specific investment expertise and seeks to bring a distinct value proposition to investors.
360° view
AXA IM Alts is a global alternative asset manager, investing both in the private and listed markets. Drawing on the expert insight of our investment professionals enables us to build a 360-degree view of the markets we operate in and to act when we identify relative value.
Established track record
Our disciplined and repeatable investment process across all our listed strategies is evidenced by our track record in various market cycles.
Listed Real Estate
Pioneer in the listed real estate equity & credit market, with AXA Group’s first fund launched in 1970.
Asset-Backed Securities
20 years’ experience managing investment grade and high yield transactions, with an eye on relative value to help deliver alpha for our investors.
Collateralized Loan Obligations
Active in the CLO market since 1999 with an expertise in structuring and managing CLOs from the most senior debt (AAA) down to the greater risk/reward of CLO Equity.
Cat Bonds
An established player in the cat bond market, with the ability to build diversified portfolios which have well-managed downside risk through a carefully selected spread of perils per geography.
Disclaimer
This marketing communication does not constitute on the part of AXA Investment Managers a solicitation or investment, legal or tax advice. This material does not contain sufficient information to support an investment decision.
Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.